{
    "Trade/Device Name(s)": [
        "ADVIA Centaur TSH",
        "ADVIA Centaur\u00ae TSH"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K141999",
    "Predicate Device Reference 510(k) Number(s)": [
        "K910981"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JLW"
    ],
    "Summary Letter Date": "March 25, 2015",
    "Summary Letter Received Date": "March 26, 2015",
    "Submission Date": "April 21, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1690"
    ],
    "Regulation Name(s)": [
        "Thyroid stimulating hormone test system"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Thyroid-stimulating hormone (TSH)",
        "Thyrotropin"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur",
        "ADVIA Centaur XP",
        "ADVIA Centaur XPT"
    ],
    "Method(s)/Technology(ies)": [
        "Two-site sandwich immunoassay",
        "Direct chemiluminometric technology"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescent immunoassay (CLIA)"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens ADVIA Centaur TSH assay using chemiluminescent immunoassay on ADVIA Centaur platforms for quantitative determination of thyroid-stimulating hormone in serum.",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of thyroid-stimulating hormone (TSH, thyrotropin) in serum using the ADVIA Centaur, ADVIA Centaur XP and ADVIA Centaur XPT systems; measurements aid in the diagnosis of thyroid or pituitary disorders.",
    "fda_folder": "Clinical Chemistry"
}